|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07J 9/00 | |
| C07J 41/00 | |||
| A61K 31/575 | |||
| A61P 1/16 | |||
| A61P 1/00 | |||
| C07J 71/00 | |||
| C07J 31/00 |
| (11) | Patento numeris | 3360881 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18163622.6 |
| Europos patento paraiškos padavimo data | 2014-05-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361823169 P | 2013-05-14 | US |
| (72) |
PELLICCIARI, Roberto, IT
|
| (73) |
Intercept Pharmaceuticals, Inc.,
10 Hudson Yards, 37th FL, New York, NY 10001,
US
|
| (54) | 11-HYDROXYL-6-SUBSTITUTED-DERIVATIVES OF BILE ACIDS AND AMINO ACID CONJUGATES THEREOF AS FARNESOID X RECEPTOR MODULATORS |
| 11-HYDROXYL-6-SUBSTITUTED-DERIVATIVES OF BILE ACIDS AND AMINO ACID CONJUGATES THEREOF AS FARNESOID X RECEPTOR MODULATORS |